Login
Registrati
Reimposta password
Pubblica & Distribuisci
Soluzioni Editoriali
Soluzioni di Distribuzione
Temi
Architettura e design
Arti
Business e Economia
Chimica
Chimica industriale
Farmacia
Filosofia
Fisica
Geoscienze
Ingegneria
Interesse generale
Legge
Letteratura
Linguistica e semiotica
Matematica
Medicina
Musica
Scienze bibliotecarie e dell'informazione, studi library
Scienze dei materiali
Scienze della vita
Scienze informatiche
Scienze sociali
Sport e tempo libero
Storia
Studi classici e del Vicino Oriente antico
Studi culturali
Studi ebraici
Teologia e religione
Pubblicazioni
Riviste
Libri
Atti
Editori
Blog
Contatti
Cerca
EUR
USD
GBP
Italiano
English
Deutsch
Polski
Español
Français
Italiano
Carrello
Home
Riviste
Radiology and Oncology
Volume 52 (2018): Numero 3 (September 2018)
Accesso libero
Pharmacogenomic markers of glucocorticoid response in the initial phase of remission induction therapy in childhood acute lymphoblastic leukemia
Vladimir Gasic
Vladimir Gasic
,
Branka Zukic
Branka Zukic
,
Biljana Stankovic
Biljana Stankovic
,
Dragana Janic
Dragana Janic
,
Lidija Dokmanovic
Lidija Dokmanovic
,
Jelena Lazic
Jelena Lazic
,
Nada Krstovski
Nada Krstovski
,
Vita Dolzan
Vita Dolzan
,
Janez Jazbec
Janez Jazbec
,
Sonja Pavlovic
Sonja Pavlovic
e
Nikola Kotur
Nikola Kotur
| 11 set 2018
Radiology and Oncology
Volume 52 (2018): Numero 3 (September 2018)
INFORMAZIONI SU QUESTO ARTICOLO
Articolo precedente
Articolo Successivo
Sommario
Articolo
Immagini e tabelle
Bibliografia
Autori
Articoli in questo Numero
Anteprima
PDF
Cita
CONDIVIDI
Article Category:
Research Article
Pubblicato online:
11 set 2018
Pagine:
296 - 306
Ricevuto:
19 feb 2018
Accettato:
24 apr 2018
DOI:
https://doi.org/10.2478/raon-2018-0034
© 2018 Vladimir Gasic, Branka Zukic, Biljana Stankovic, Dragana Janic, Lidija Dokmanovic, Jelena Lazic, Nada Krstovski, Vita Dolzan, Janez Jazbec, Sonja Pavlovic, Nikola Kotur, published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.
Vladimir Gasic
Laboratory for Molecular Biomedicine, Institute of Molecular Genetics and Genetic Engineering University of Belgrade
Belgrade, Serbia
Branka Zukic
Laboratory for Molecular Biomedicine, Institute of Molecular Genetics and Genetic Engineering University of Belgrade
Belgrade, Serbia
Biljana Stankovic
Laboratory for Molecular Biomedicine, Institute of Molecular Genetics and Genetic Engineering University of Belgrade
Belgrade, Serbia
Dragana Janic
Department of Hematology and Oncology, University Children’s Hospital, University of Belgrade
Belgrade, Serbia
Lidija Dokmanovic
Department of Hematology and Oncology, University Children’s Hospital, University of Belgrade
Belgrade, Serbia
Jelena Lazic
Department of Hematology and Oncology, University Children’s Hospital, University of Belgrade
Belgrade, Serbia
Nada Krstovski
Department of Hematology and Oncology, University Children’s Hospital, University of Belgrade
Belgrade, Serbia
Vita Dolzan
Pharmacogenetics Laboratory, Institute of Biochemistry, Faculty of Medicine University of Ljubljana
Ljubljana, Slovenia
Janez Jazbec
Department of Oncology and Haematology, University Children’s Hospital, University Medical Centre Ljubljana
Ljubljana, Slovenia
Sonja Pavlovic
Laboratory for Molecular Biomedicine, Institute of Molecular Genetics and Genetic Engineering University of Belgrade
Belgrade, Serbia
Nikola Kotur
Laboratory for Molecular Biomedicine, Institute of Molecular Genetics and Genetic Engineering University of Belgrade
Belgrade, Serbia